Dr. Paul Richardson
Claim this profileDana-Farber Cancer Institute
Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasm
12 reported clinical trials
20 drugs studied
Area of expertise
1Multiple Myeloma
Global LeaderHLA-A positive
HBcAb positive
HBsAg negative
2Plasma Cell Neoplasm
Global LeaderHLA-A positive
HBcAb positive
HBsAg negative
Affiliated Hospitals
Clinical Trials Paul Richardson is currently running
CFT7455
for Lymphoma
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.
Recruiting1 award Phase 1 & 210 criteria
Defibrotide
for COVID-19
The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia.
Recruiting3 awards Phase 28 criteria
More about Paul Richardson
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Paul Richardson has experience with
- Dexamethasone
- Bortezomib
- Lenalidomide
- Daratumumab
- Carfilzomib
- CC-92480
Breakdown of trials Paul Richardson has run
Multiple Myeloma
Plasma Cell Neoplasm
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Richardson specialize in?
Paul Richardson focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved HLA-A positive patients, or patients who are HBcAb positive.
Is Paul Richardson currently recruiting for clinical trials?
Yes, Paul Richardson is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Paul Richardson has studied deeply?
Yes, Paul Richardson has studied treatments such as Dexamethasone, Bortezomib, Lenalidomide.
What is the best way to schedule an appointment with Paul Richardson?
Apply for one of the trials that Paul Richardson is conducting.
What is the office address of Paul Richardson?
The office of Paul Richardson is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.